Rapross Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 1995.
1995 Delhi, Delhi, India Active
Last Updated:
Access Report
About Rapross Pharmaceuticals Private Limited

Rapross Pharmaceuticals Private Limited, a active private limited company, was established on 22 March 1995 in Delhi, Delhi, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U74899DL1995PTC066606. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Employing 326 professional, Its leadership includes Nimit Bansal (Additional Director), Sharad Verma (Additional Director), Parveen Kumar Bansal (Director). Past directors included Navneet Bagga, Parveen Kumar Bansal, Kanika Jain. It holds no open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ii Floor Garg Plaza, 5 Community Centre, Sector- 8 , Rohini, Delhi, Delhi, 110085.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1995PTC066606

  • Registration Number

    066606

  • Incorporation Date

    22 March 1995

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 2.50 M
  • Company Age 30 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 5.00 Cr
  • Revenue Growth **** 2.73%
  • Profit Growth **** -3.90%
  • Ebitda **** 22.62%
  • Net Worth 11.86%
  • Total Assets **** 29.08%
Company report

Rapross Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rapross Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rapross Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nimit Bansal Additional Director 01 Sep 2023 Current
Sharad Verma Additional Director 01 Sep 2023 Current
Parveen Kumar Bansal Director 04 Apr 1995 Current
Ranjan Verma Director 04 Apr 1995 Current
Shailendra Singh Additional Director 11 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 01 Feb 2024 Past
Pramod Abcsdd Director 06 Jul 2016 Past
Pramod Abcsdd Director 25 Jul 2015 Past
Pramod Abcsdd Additional Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rapross Pharmaceuticals.

Rapross Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.73% increase. The company also saw a slight decrease in profitability, with a 3.9% decrease in profit. The company's net worth Soared by an impressive increase of 11.86%.

Rapross Pharmaceuticals revenue growth over time
Rapross Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.73%
*******
*******
*******
*******
Revenue from Operations
*******
 3.36%
*******
*******
*******
*******
Total Assets
*******
 29.08%
*******
*******
*******
*******
Profit or Loss
*******
 -3.90%
*******
*******
*******
*******
Net Worth
*******
 11.86%
*******
*******
*******
*******
EBITDA
*******
 22.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rapross Pharmaceuticals?

Unlock access to Rapross Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹50,000,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 5.00 Cr
Latest Charge Details
Date Lender Amount Status
04 Jul 2022 Axis Bank Limited ₹5.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Rapross Pharmaceuticals?

Rapross Pharmaceuticals has a workforce of 326 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rapross Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rapross Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rapross Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Shailendra Singh was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2025 & has been associated with this company since 6 months 28 days . was documented.

  • Annual General Meeting

    The activity Rapross Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Rapross Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Nimit Bansal was appointed as a Additional Director was appointed as a Additional Director on 01 Sep 2023 & has been associated with this company since 2 years 6 months . was documented.

  • Director Appointment

    Progress on Sharad Verma was appointed as a Additional Director was appointed as a Additional Director on 01 Sep 2023 & has been associated with this company since 2 years 6 months . was documented.

  • Charges

    A charge registered on 04 Jul 2022 via Charge ID 100597623 with Axis Bank Limited was fully satisfied on 28 Aug 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rapross Pharmaceuticals Private Limited?

The CIN of Rapross Pharmaceuticals Private Limited is U74899DL1995PTC066606.

Where is Rapross Pharmaceuticals Private Limited headquartered?

Rapross Pharmaceuticals Private Limited is headquartered at Ii Floor Garg Plaza, 5 Community Centre, Sector- 8 , Rohini, Delhi, Delhi, 110085.

When was Rapross Pharmaceuticals Private Limited incorporated?

Rapross Pharmaceuticals Private Limited was incorporated on 22 March 1995.

Who are the current directors of Rapross Pharmaceuticals Private Limited?

The current directors of Rapross Pharmaceuticals Private Limited are

What is the primary industry of Rapross Pharmaceuticals Private Limited?

The primary industry of Rapross Pharmaceuticals Private Limited is Manufacturing.

Is Rapross Pharmaceuticals Private Limited a listed company?

Rapross Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Rapross Pharmaceuticals Private Limited?

The authorized capital of Rapross Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹2.50 M.

What is the compliance status of Rapross Pharmaceuticals Private Limited?

The compliance status of Rapross Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available